A Pharmaco-Therapeutic Study of Varun and Indrayava in Vatarakta w.s.r to Gout
Trial Snapshot
- Phase
- Phase 2/3
- Status
- Completed
- Sponsor
- Enrollment
- 60
- Locations
- 1
- Primary Endpoint
- Improvement in the patient will be assessed mainly on the basis of relief in cardinal symptoms of disease. To access the effect of drug therapy subjectively, all sign & symptoms will be relief in
Study Overview
Brief Summary
Vatarakta is a chronic is a chronic and complex metabolic disorder of musculoskeletal system and characterised by severe pain, tenderness, inflammation and burning sensation in the affected joints. Vatarakta is a Vatapradhana Vyadhi where Rakta is main Dushya. The drug used in this trial is Varun churna and Indrayava churna mentioned in Ayurveda text with hope that they will prove more efficacious, less toxic and easy to use. This drug is easily available and effective in Vatarakta. Patient will be taken from OPD and IPD of Government Ayurvedic College and Hospital Patna. Duration of trial is 30 days.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 20.00 Year(s) to 60.00 Year(s) (—)
- Sex
- All
Inclusion Criteria
- •Patient willing for Trial.
- •Patient having symptoms of Vatarakta vyadhi as per ayurvedic classic and Gout w.s.r to modern view have include under the study.
- •Patient having age between 20-60 year who can present their sign and symptoms of Vatarakta.
Exclusion Criteria
- •Patients who have HIV HCV CKD etc Patients suffering from serious systemic disorder like Diabetes Renal Calculus Hepatic Disorder are excluded Cardiac patients Cancer patient On Chemotherapy patient On Dialysis patient are excluded Patient who have suffering from serious lungs disorders Asthmaticus Bronchogenic Carcinoma or other types of malignancy Pregnant and Lactating Women Anemia- less than hemoglobin 9mgdl.
Outcomes
Primary Outcomes
Improvement in the patient will be assessed mainly on the basis of relief in cardinal symptoms of disease. To access the effect of drug therapy subjectively, all sign & symptoms will be relief in
Time Frame: 60 Days (8 weeks)
1. pain in affected joint.
Time Frame: 60 Days (8 weeks)
2. swelling in the affected joint.
Time Frame: 60 Days (8 weeks)
3. law of tactile sensation. upon their severity.
Time Frame: 60 Days (8 weeks)
Secondary Outcomes
- chaneges in serum uric acid and blood urea(60 days)
Investigators
Dr Raj Kishor Verma
Government Ayurvedic College and Hospital Patna